Related Experiment Video
Updated: May 8, 2026
04:01
Revealing the Ferroptotic Phenotype of Medulloblastoma
Published on: March 15, 2024
[Research progress in hypoxanthine-guanine phosphoribosyltrans-ferase]
Hui Ding1, Li-Jie Yue, Chun-Lan Yang
1Insitute of Pediatrics Research, Shenzhen Children's Hospital of Chongqing Medical University, Shenzhen 518026, China
Yi Chuan = Hereditas
|August 20, 2013
Summary
Hypoxanthine-guanine phosphoribosyltransferase (HPRT) impacts purine metabolism and drug responses. Research advances HPRT
Area of Science:
- Biochemistry and Molecular Biology
- Pharmacology and Toxicology
- Genetics and Inherited Diseases
Background:
- Hypoxanthine-guanine phosphoribosyltransferase (HPRT) is a key enzyme in purine salvage pathways.
- HPRT plays a crucial role in the metabolism and efficacy of purine analogue drugs.
- Mutations in the HPRT gene can lead to inherited metabolic disorders and affect drug responses.
Purpose of the Study:
- To review recent advancements in HPRT research.
- To highlight HPRT's role in personalized medicine for purine analogue drugs.
- To discuss HPRT's significance in diagnosing and treating inherited metabolic diseases.
Main Methods:
- Literature review of recent scientific publications on HPRT.
- Analysis of HPRT's involvement in purine metabolism and drug interactions.
- Examination of HPRT gene mutations and their clinical implications.
Main Results:
- HPRT is vital for purine salvage and influences purine analogue drug pharmacology and toxicity.
- HPRT gene mutations cause various metabolic diseases and alter purine analogue metabolism.
- The HPRT gene serves as a diagnostic marker for numerous disorders.
Conclusions:
- HPRT research is crucial for advancing personalized treatment strategies for purine analogue drugs.
- Understanding HPRT is key to developing novel therapeutic agents.
- HPRT research improves the diagnosis and management of HPRT-related inherited metabolic diseases.
Related Concept Videos
01:28Biosynthesis of Nucleic Acids
Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:27Transducer Mechanism: Enzyme-Linked Receptors
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
02:28Leaky Scanning
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...